Clinical Trial Update: Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing talnetant, risperidone, and placebo in schizophrenic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Talnetant (talnetant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED